NANO MRNALtd Management
Management criteria checks 1/4
NANO MRNALtd's CEO is Shiro Akinaga, appointed in Dec 2022, has a tenure of 2.08 years. directly owns 0.29% of the company’s shares, worth ¥30.45M. The average tenure of the management team and the board of directors is 2 years and 2.6 years respectively.
Key information
Shiro Akinaga
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2yrs |
| Board average tenure | 2.6yrs |
Recent management updates
CEO
Shiro Akinaga (68 yo)
2.1yrs
Tenure
Dr. Shiro Akinaga, Ph.D. serves as Director at NANO MRNA Co.,Ltd. (formerly known as NanoCarrier Co., Ltd.) since June 2020 and serves as its President and Chief Executive Officer since December 2022 and h...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.8yrs | no data | no data | |
| President | 2.1yrs | no data | 0.29% ¥ 30.5m | |
| Executive Officer & CFO | 1.6yrs | no data | 0.051% ¥ 5.3m |
2.0yrs
Average Tenure
62yo
Average Age
Experienced Management: 4571's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.8yrs | no data | no data | |
| President | 4.6yrs | no data | 0.29% ¥ 30.5m | |
| Outside Audit & Supervisory Board Member | 1.6yrs | no data | no data | |
| Chairman of Standing Audit & Supervisory Board | 1.6yrs | no data | 0.19% ¥ 19.9m | |
| Independent Director | 3.6yrs | no data | no data | |
| Outside Audit & Supervisory Board Member | 1.6yrs | no data | no data |
2.6yrs
Average Tenure
62yo
Average Age
Experienced Board: 4571's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 12:12 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NANO MRNA Co.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kiyokazu Yamazaki | Ichiyoshi Research Institute Inc. |
| Hironoshin Nomura | Mizuho Securities Co., Ltd. |
| Pravin Gondhale | Virtua Research Inc. |